4,373.87 31.80% Cost of sales and services 1,420.50 2,060.70 1,405.95 1.03% (31.07%) 5,689.39 4,008.09 41.95% Gross profit (113.70) 46.01 108.37 (204.93%) (347.12%) 75.53 365.78 (79.35%) Other income 1.23
and services 7,724.99 100.00% 6,431.56 100.00% 1,293.43 20.11% Cost of sales and services 7,681.74 99.44% 5,890.19 91.58% 1,791.55 30.42% Gross profit 43.25 0.56% 541.37 8.42% (498.12) -92.01% Other
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
2022 1st quarter 2022 2nd quarter 2021 % Increase (Decrease) Six-month period % YoY QoQ 2022 2021 Revenue from sales and services 2,106.71 2,351.40 1,404.30 50.02% (10.41%) 4,458.11 2,859.55 55.90% Cost
company had adjust the organization to be more compact and more cost saving. 6. Financial cost For Quarter 1 of the year 2020, the financial cost was 0.21 million baht compare to 0.44 million bath last year
or 27.27 percent decreased by following details; Cost of goods sold as amount of 282.16 Million Baht as 99.25 Million Baht decreased or 26.02 percent when compared to same period of previous year of
significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 2 of the year 2020, the company had cost of sale of 98.72 million bath compare to 93.54 million baht last year with the increasing of
2022 % 2021 % Increase (Decrease) % Revenue from sales and services 2,351.40 100.00% 1,455.25 100.00% 896.15 61.58% Cost of sales and services 2,208.18 93.91% 1,319.00 90.64% 889.18 67.41% Gross profit
/2017 by 6 MB or 24.1 percent (25 MB in Q1/2017) mainly decreased from Consultant Fee, Accounting Software Amortization etc. Finance Cost Q1/2018, the Company and its subsidiaries have the financial
majority of these projects delivered within/before June-July. And another reason is a one- time charge of 13 million Baht to adjust the retirement benefits in accordance with the latest changes in Labor